These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
278 related items for PubMed ID: 23022357
1. Role of serine proteases in inflammation: Bowman-Birk protease inhibitor (BBI) as a potential therapy for autoimmune diseases. Safavi F, Rostami A. Exp Mol Pathol; 2012 Dec; 93(3):428-33. PubMed ID: 23022357 [Abstract] [Full Text] [Related]
2. Bowman-Birk inhibitor suppresses autoimmune inflammation and neuronal loss in a mouse model of multiple sclerosis. Touil T, Ciric B, Ventura E, Shindler KS, Gran B, Rostami A. J Neurol Sci; 2008 Aug 15; 271(1-2):191-202. PubMed ID: 18544456 [Abstract] [Full Text] [Related]
3. The protease inhibitor, Bowman-Birk Inhibitor, suppresses experimental autoimmune encephalomyelitis: a potential oral therapy for multiple sclerosis. Gran B, Tabibzadeh N, Martin A, Ventura ES, Ware JH, Zhang GX, Parr JL, Kennedy AR, Rostami AM. Mult Scler; 2006 Dec 15; 12(6):688-97. PubMed ID: 17262995 [Abstract] [Full Text] [Related]
4. Interleukin-10 plays a crucial role in suppression of experimental autoimmune encephalomyelitis by Bowman-Birk inhibitor. Dai H, Ciric B, Zhang GX, Rostami A. J Neuroimmunol; 2012 Apr 15; 245(1-2):1-7. PubMed ID: 22365083 [Abstract] [Full Text] [Related]
5. Bowman-Birk inhibitors from legumes as colorectal chemopreventive agents. Clemente A, Arques Mdel C. World J Gastroenterol; 2014 Aug 14; 20(30):10305-15. PubMed ID: 25132747 [Abstract] [Full Text] [Related]
6. Biological significance of polymorphism in legume protease inhibitors from the Bowman-Birk family. Clementea A, Domoney C. Curr Protein Pept Sci; 2006 Jun 14; 7(3):201-16. PubMed ID: 16787260 [Abstract] [Full Text] [Related]
7. Soybean Bowman-Birk protease inhibitor is a highly effective inhibitor of human mast cell chymase. Ware JH, Wan XS, Rubin H, Schechter NM, Kennedy AR. Arch Biochem Biophys; 1997 Aug 01; 344(1):133-8. PubMed ID: 9244390 [Abstract] [Full Text] [Related]
8. Bowman-Birk Inhibitor attenuates experimental autoimmune encephalomyelitis by delaying infiltration of inflammatory cells into the CNS. Dai H, Ciric B, Zhang GX, Rostami A. Immunol Res; 2011 Dec 01; 51(2-3):145-52. PubMed ID: 22095543 [Abstract] [Full Text] [Related]
9. The cytotoxic effect of Bowman-Birk isoinhibitors, IBB1 and IBBD2, from soybean (Glycine max) on HT29 human colorectal cancer cells is related to their intrinsic ability to inhibit serine proteases. Clemente A, Moreno FJ, Marín-Manzano Mdel C, Jiménez E, Domoney C. Mol Nutr Food Res; 2010 Mar 01; 54(3):396-405. PubMed ID: 19885848 [Abstract] [Full Text] [Related]
10. Attenuation of skeletal muscle atrophy via protease inhibition. Morris CA, Morris LD, Kennedy AR, Sweeney HL. J Appl Physiol (1985); 2005 Nov 01; 99(5):1719-27. PubMed ID: 15976355 [Abstract] [Full Text] [Related]
11. The biochemical and functional food properties of the bowman-birk inhibitor. Losso JN. Crit Rev Food Sci Nutr; 2008 Jan 01; 48(1):94-118. PubMed ID: 18274967 [Abstract] [Full Text] [Related]
12. Study of antiproteinase activity of acylated derivatives of Bowman-Birk soybean proteinase inhibitor. Malykh EV, Larionova NI. Biochemistry (Mosc); 2002 Dec 01; 67(12):1383-7. PubMed ID: 12600268 [Abstract] [Full Text] [Related]
13. Bowman-Birk inhibitors from legumes and human gastrointestinal health: current status and perspectives. Clemente A, Sonnante G, Domoney C. Curr Protein Pept Sci; 2011 Aug 01; 12(5):358-73. PubMed ID: 21418025 [Abstract] [Full Text] [Related]
14. Effect of the Bowman-Birk inhibitor (a soy protein) on in vitro bladder neck/urethral and penile corporal smooth muscle activity. Malkowicz SB, Liu SP, Broderick GA, Wein AJ, Kennedy AR, Levin RM. Neurourol Urodyn; 2003 Aug 01; 22(1):54-7. PubMed ID: 12478602 [Abstract] [Full Text] [Related]
15. Detection of Bowman-Birk inhibitor and anti-Bowman-Birk inhibitor antibodies in sera of humans and animals treated with Bowman-Birk inhibitor concentrate. Wan XS, Serota DG, Ware JH, Crowell JA, Kennedy AR. Nutr Cancer; 2002 Aug 01; 43(2):167-73. PubMed ID: 12588697 [Abstract] [Full Text] [Related]
16. Therapeutic potential of the peptide leucine arginine as a new nonplant bowman-birk-like serine protease inhibitor. Rothemund S, Sönnichsen FD, Polte T. J Med Chem; 2013 Sep 12; 56(17):6732-44. PubMed ID: 23988198 [Abstract] [Full Text] [Related]
17. Novel alleles among soybean Bowman-Birk proteinase inhibitor gene families. Wang Y, Chen X, Qiu L. Sci China C Life Sci; 2008 Aug 12; 51(8):687-92. PubMed ID: 18677596 [Abstract] [Full Text] [Related]
18. Relationship between protease activity and neu oncogene expression in patients with oral leukoplakia treated with the Bowman Birk Inhibitor. Wan XS, Meyskens FL, Armstrong WB, Taylor TH, Kennedy AR. Cancer Epidemiol Biomarkers Prev; 1999 Jul 12; 8(7):601-8. PubMed ID: 10428197 [Abstract] [Full Text] [Related]
19. In vivo anti-inflammatory efficacy of the combined Bowman-Birk trypsin inhibitor and genistein isoflavone, two biological compounds from soybean. Sadeghalvad M, Mohammadi-Motlagh HR, Karaji AG, Mostafaie A. J Biochem Mol Toxicol; 2019 Dec 12; 33(12):e22406. PubMed ID: 31593353 [Abstract] [Full Text] [Related]
20. The radioprotector Bowman-Birk proteinase inhibitor stimulates DNA repair via epidermal growth factor receptor phosphorylation and nuclear transport. Dittmann K, Mayer C, Kehlbach R, Rodemann HP. Radiother Oncol; 2008 Mar 12; 86(3):375-82. PubMed ID: 18237807 [Abstract] [Full Text] [Related] Page: [Next] [New Search]